Alcohol-related Liver Disease and sepsis

Area of Science:

• Hepatology
• Infectious Diseases
• Immunology

Background:

• Alcohol-related Liver Disease (ARLD) significantly increases the risk of sepsis, a leading cause of mortality.
• Impaired immune function and gut dysbiosis contribute to heightened susceptibility to infections in ARLD patients.
• Sepsis diagnosis and management are complicated by the unique pathophysiology of ARLD.

Purpose of the Study:

• To review the multifaceted aspects of sepsis in patients with Alcohol-related Liver Disease.
• To elucidate the pathophysiological mechanisms underlying increased infection risk in ARLD.
• To discuss diagnostic challenges, treatment strategies, and preventive measures for sepsis in this vulnerable population.

Main Methods:

• This study is a narrative review of existing literature.
• It synthesizes information on the pathophysiology, diagnosis, and treatment of sepsis in ARLD.
• Focuses on immune dysfunction, gut microbiota alterations, and diagnostic marker limitations.

Main Results:

• Alcohol abuse and liver disease impair both innate and adaptive immunity, increasing infection susceptibility.
• Gut microbiota changes lead to bacterial translocation, further elevating sepsis risk.
• Traditional sepsis biomarkers like C-reactive protein and procalcitonin have limited utility in ARLD patients.

Conclusions:

• Early and appropriate antibiotic therapy is critical for managing sepsis in ARLD.
• Effective infection control and prevention strategies are essential due to the poor prognosis.
• Further research is needed to improve diagnostic tools and therapeutic outcomes for sepsis in ARLD.